AI-generated summary
The authors report on 670-nm low-level laser therapy for recurrent labial herpes simplex type 1 in two studies, one comparing laser with acyclovir and one following laser-treated patients for five years. They report an obvious effect on healing time and on the length of recurrence periods, and conclude the treatment appeared effective without observed side effects. The abstract does not describe a control design for the second study.
- Participants
- 232
- Who or what was studied
- Patients with recurrent labial herpes simplex type 1 infections; 232 patients in the initial comparison study and 322 patients in the consecutive 5-year follow-up study
- Wavelengths
- 670 nm
- Limits stated in the abstract
- The abstract does not describe randomization or blinding beyond a semi-blinded procedure, and the second study's follow-up design and comparison group are not stated.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.sagepub.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Power
- 40 mW
- Total energy
- 1.6 J, 4.8 J, 1.2 J
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.